002932 明德生物
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(123,266)392,4984,012,8481,127,006359,682
投资活动产生之现金流量净额(144,744)(1,365,066)(2,234,199)(685,118)(43,369)
筹资活动产生之现金流量净额(250,644)(670,060)(432,790)82,272182,921
汇率变动对现金及现金等价物的影响(1,050)1,26219,471(3,196)(639)
现金及现金等价物净增加/(减少)(519,704)(1,641,365)1,365,330520,964498,596
期初现金及现金等价物余额914,0402,555,4051,190,075669,111170,515
期末现金及现金等价物余额394,336914,0402,555,4051,190,075669,111